RecruitingNCT01477359

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Studying Sarcoidosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Ottawa Heart Institute Research Corporation
Principal Investigator: David Birnie, MD
Ottawa Heart Institute Research Corporation
Enrollment: 1500 target
Eligibility: 18-99 years · All sexes
Timeline: 2012 – 2025

Study locations (14)

Libin Cardiovascular Institute of Alberta, Calgary, Alberta, Canada
University of Alberta Hospital, Edmonton, Alberta, Canada
St. Paul's Hospital, Vancouver, British Columbia, Canada
QEII Health Sciences Center, Halifax, Nova Scotia, Canada
Hamilton Health Sciences Centre, Hamilton, Ontario, Canada
London Health Sciences Centre, London, Ontario, Canada
Southlake Regional Health Centre, Newmarket, Ontario, Canada
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Toronto General Hospital, Toronto, Ontario, Canada
Montreal Heart Institute, Montreal, Quebec, Canada
Centre Hospitalier de l"Universite de Montreal-Hotel Dieu, Montreal, Quebec, Canada
McGill University Health Centre, Montreal, Quebec, Canada
Prairie Vascular Research Inc-Regina General Hospital, Regina, Saskatchewan, Canada
Hokkaido University, Sapporo, Japan

Collaborators

Ontario Ministry of Health and Long Term Care · Canadian Institutes of Health Research (CIHR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01477359 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials